Strategic Roadmap and Financial Performance slide image

Strategic Roadmap and Financial Performance

Key Highlights | Strong Performance, Underlying Growth 1 Total income grew 12% to AED 46.9 MN in 1Q-2022 vs. the AED 42.0 million recorded in 1Q-2021. On an adjusted basis, excluding the prior year result from divested entities total income grew 40% to AED 46.9 MN vs. AED 33.5 million recorded in 1Q-2021. 2 Growth of 66% year-on-year in adjusted EBITDA, to record AED 48.5 MN in 1Q-2022 vs. 29.3 MN in 1Q-2021. Strong growth in underlying performance with adjusted Net Profit of AED 32.1 MN, growth of AED 9.0 MN or 39% vs. AED 23.1 MN in 1Q-2021 3 4 5 Healthcare platform growth of AED 11.5 MN or 5x, positively impacted by the full quarter inclusion of CMRC (+AED 9.2 MN), 2x revenue growth at RHWC significantly reducing losses (+AED 1.7 MN or 41%) and revenue growth at Sukoon (+AED 0.3 MN) Steady growth at the Education platform (+AED 0.9 MN or 3%), with record enrollments at Middlesex (4k students, 16% increase and the #1 ranked private education institution in Dubai by enrollments), driving +AED 2.5 MN or 18% growth in profitability, partly offset by post-COVID normalization at NEMA Holding AED 887 MN of cash at quarter end, to be utilized, with potential additional leverage, against a strong deployment pipeline and post period dividend settlement. Facility expansion at Sukoon and ramp-up of CMRC KSA & RHWC in progress 8
View entire presentation